Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Conditions

• NHL
• Lymphoma, Non-Hodgkin
• Lymphoma, B-Cell
• Lymphoma, Follicular
• Lymphoma, Intermediate-Grade
• Lymphoma, Large-Cell
• Lymphoma, Low-Grade
• Lymphoma, Mixed-Cell
• Lymphoma, Small-Cell
• Leukemia, Lymphocytic, Chronic
• Leukemia, B-Cell, Chronic
• Leukemia, Prolymphocytic
• Leukemia, Small Lymphocytic
• Lymphoma, Small Lymphocytic
• Lymphoma, Lymphoplasmacytoid, CLL
• Lymphoplasmacytoid Lymphoma, CLL
• CLL
• SLL

Interventions

• BIOLOGICAL: veltuzumab

Sponsor

Gilead Sciences